Emmaus Life Sciences, Inc. (EMMA)
0.013
0.00 (0.00%)
USD |
OTCM |
Dec 29, 16:00
Emmaus Life Sciences EPS Diluted (Quarterly): -0.0325 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | -1.569 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Electromed, Inc. | 0.246 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.076M |
| Revenue (Quarterly) | 3.378M |
| Total Expenses (Quarterly) | 5.454M |
| Enterprise Value | 32.22M |
| Gross Profit Margin (Quarterly) | 92.69% |
| Profit Margin (Quarterly) | -61.46% |
| Earnings Yield | -878.5% |
| Normalized Earnings Yield | -940.00 |